Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
16 January 2025 - preview of changes for February 2025
|
Pharmaceutical |
Change |
|---|---|
|
Amoxicillin with clavulanic acid inj 500 mg with clavulanic acid 100 mg vial and inj 1,000 mg with clavulanic acid 200 mg vial |
Brand change Synermox – new listing and addition of PSS
Amoxiclav Multichem to be delisted 1 |
|
Antithymocyte globulin (equine) (ATGAM) inj 50 mg per ml, 5 ml ampoule |
price increase |
|
Atorvastatin (Lorstat) tab 10 mg and 80 mg, 30 tab pack |
new listing
|
|
Baricitinib (Olumiant) tab 2 mg and 4 mg |
delisted 1 February 2025 |
|
Bedaquiline (Sirturo) tab 100 mg |
delisted 1 February 2025 |
|
Bee venom (VENOX) initiation kit – 1 vial freeze dried venom with diluent |
new listing (p’code 2698773) |
|
Bee venom (VENOX) initiation kit – 5 vials freeze dried venom with diluent |
to be delisted 1 May 2025 |
|
Benzathine benzylpenicillin (Bicillin LA) inj 900 mg (1.2 million units) in 2.3 ml syringe |
price increase |
|
Carboplatin (DBL Carboplatin) inj 10 mg per ml, 45 ml vial |
new listing (p’code 2698943) |
|
Clomipramine hydrochloride (APO |
new listing and addition of PSS (p’code 2565773) |
|
Clomipramine hydrochloride (Clomipramine Teva) tab 10 mg and 25 mg and cap 10 mg and 25 mg |
to be delisted 1 July 2025 |
|
Cyproterone acetate (Siterone) tab 50 mg and 100 mg |
price increase and addition of PSS
|
|
Dantrolene cap 25 mg (Dantrium) and inj 20 mg vial (Dantrium IV) |
price increase |
|
Denosumab (Xgeva) inj 120 mg per 1.7 ml vial |
new listing (p’code 2594870) |
|
Denosumab inj 60 mg prefilled syringe (Prolia) and inj 120 mg per 1.7 ml vial (Xgeva) |
note added and amended restriction |
|
Desferrioxamine mesilate (DBL |
price increase |
|
Diclofenac sodium (Diclofenac Devatis) eye drops 0.1%, single dose, 10 dose and 30 dose |
new listing and addition of PSS
|
|
Efavirenz with emtricitabine and tenofovir disoproxil (Triovir) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate) |
new listing (p’code 2698935) |
|
Entacapone tab 200 mg |
Brand change
|
|
Enteral feed 1.5 kcal/ml (Fresubin HP Energy) liquid 7.5 g protein, 17 g carbohydrate and 5.8 g fat per 100 ml, bag, 1,000 ml |
delisted 1 February 2025 |
|
Enteral feed 1 kcal/ml (Fresubin Original) liquid 3.8 g protein, 13.8 g carbohydrate and 3.4 g fat per 100 ml, bag, 1,000 ml |
delisted 1 February 2025 |
|
Enteral feed with fibre 1 kcal/ml (Fresubin Original Fibre) liquid 3.8 g protein, 13.0 g carbohydrate, 3.4 g fat and 1.5 g fibre per 100 ml, bag, 1,000 ml |
delisted 1 February 2025 |
|
Enteral feed with fibre 1.5 kcal/ml (Fresubin HP Energy Fibre) liquid 7.5 g protein, 16.2 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, bag, 1,000 ml |
delisted 1 February 2025 |
|
Enteral feed 2 kcal/ml (Fresubin 2kcal HP) liquid 10 g protein, 17.5 g carbohydrate and 10 g fat per 100 ml, bag |
delisted 1 February 2025 |
|
Fexofenadine hydrochloride (Fexaclear) tab 120 mg and 180 mg |
new listing and addition of PSS
|
|
High protein enteral feed 1.2 kcal/ml (Fresubin Intensive) liquid 10 g protein, 12.9 g carbohydrate and 3.2 g fat and 0.64 g fibre per 100 ml, bag, 500 ml |
delisted 1 February 2025 |
|
Hydroxocobalamin (Hydroxocobalamin Panpharma) inj 1 mg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Itraconazole (Itracap) cap 100 mg |
new listing (p’code 2698560) |
|
Levodopa with carbidopa and entacapone (Stalevo) tab 50 mg with carbidopa 12.5 mg and entacapone 200 mg, tab 100 mg with carbidopa 25 mg and entacapone 200 mg, tab 150 mg with carbidopa 37.5 mg and entacapone 200 mg and tab 200 mg with carbidopa 50 mg and entacapone 200 mg |
new listing and addition of PSS
|
|
Medroxyprogesterone acetate (Depo-Provera) inj 150 mg per ml, 1 ml syringe |
price increase |
|
Methylprednisolone (as sodium succinate) inj 500 mg vial (Solu-Medrol Act-O-Vial) and inj 1 g vial (Solu-Medrol) |
price increase |
|
Nepafenac eye drops 0.3% |
to be delisted 1 July 2025 |
|
Pazopanib (Pazopanib Teva and Votrient) tab 200 mg and 400 mg |
amended restriction criteria |
|
Paediatric enteral feed 1 kcal/ml (Frebini Original) liquid 2.5 g protein, 12.5 g carbohydrate and 4.4 g fat per 100 ml, 500 ml |
delisted 1 February 2025 |
|
Paediatric enteral feed 1.5 kcal/ml (Frebini Energy) liquid 3.8 g protein, 18.7 g carbohydrate and 6.7 g fat per 100 ml, 500 ml |
delisted 1 February 2025 |
|
Paediatric enteral feed with fibre 1 kcal/ml (Frebini Original Fibre) liquid 2.5 g protein, 12.1 g carbohydrate, 4.5 g fat and 0.8 g fibre per 100 ml, 500 ml |
delisted 1 February 2025 |
|
Paediatric enteral feed with fibre 1.5 kcal/ml (Frebini Energy Fibre) liquid 3.8 g protein, 18.1 g carbohydrate, 6.7 g fat and 1.1 g fibre per 100 ml, 500 ml |
delisted 1 February 2025 |
|
Peptide-based enteral feed 1kcal/ml (Survimed OPD) liquid 4.5 g protein, 14.3 g carbohydrate and 2.8 g fat per 100 ml, bag, 500 ml |
delisted 1 February 2025 |
|
Phenylephrine hydrochloride (Neosynephrine HCL) inj 10 mg per ml, 1 ml ampoule |
price increase |
|
Salbutamol (SalAir) aerosol inhaler, 100 mcg per dose, 200 dose |
price increase |
|
Sulfasalazine tab 500 mg (Salazopyrin) and tab EC 500 mg (Salazopyrin EN) |
price increase |
|
Sunitinib (Sunitinib Pfizer) cap 12.5 mg, 25 mg and 50 mg |
amended restriction criteria |